Global Gynecology Medical Lasers Market

The 3D printed medical prosthetics market consist of sales of 3D printed medical prosthetics devices and related services. 3D printing technology is used to create an artificial three dimensions’ physical object with the help of computer-aided design, and these prosthetics are intended to help patients with missing or defective body parts to restore normal functions. The global 3D printed prosthetics market is expected grow from $0.06 billion in 2020 to $0.07 billion in 2021 at a compound annual growth rate (CAGR) of 16.7%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $0.12 billion in 2025 at a CAGR of 14%. The 3D printed medical prosthetics market covered in this report is segmented by material into polypropylene, polyethylene, acrylics, polyurethane. The rising number of accidental injuries is driving the growth of the 3D printing prosthetic devices market. Accidental injuries can cause serious damage to a person, and these injuries can sometimes lead to amputation. In 2019, car crashes in the US resulted in the death of 38,800 people. According to a report from National Centre for Health Statistics, approximately 50,000 new amputation cases come up each year in the US. Increase in incidences of other medical conditions such as diabetes and vascular diseases is also leading to a rise in amputation cases, thus boosting the sales of 3D printing prosthetics. For instance, according to a report published in the American Journal of Managed Care, it was estimated that, globally, one patient leg is amputated in every 30 seconds and around 85% of these amputations were result of a diabetic foot ulcer. The delay in elective procedures attributing to the coronavirus outbreak is to act as a major factor to limit the growth of the 3D printed medical prosthetics market. Many countries and hospitals have diverted their healthcare resources to deal with COVID-19 patients. For instance, according to the Centers for Medicare & Medicaid Services (CMS) safety guidelines released in March 2020, all the elective and non-essential surgical, dental, and medical procedures are delayed in the USA during 2019 Novel Coronavirus (COVID-19) outbreak. Hence, the delays in surgical or elective procedures are projected to decline the demand for 3D printed medical prosthetics market in the near future. Companies in the 3D printing prosthetics market are focusing on development of waterproof prosthetic devices. The aim behind this innovation is to provide the user with an increased range of mobility, especially in athletics. In October 2020, Braskem, Americas leading producer of biopolymers has launched Braskem e-NABLE Chapter for Philanthropic Creation of 3D Printed Prosthetic Devices. Braskem was selected to be certified to produce the e-NABLE Phoenix V3 prosthetic hand as it is one of the most commonly produced e-NABLE prosthetic devices. The major players covered in the global 3d printed prosthetics market are 3D Systems corporation, EnvisionTEC, Stratasys Ltd., Bionicohand, YouBionic, UNYQ, Mecuris, LimbForge, Inc., Open Bionics, Protosthetics, Create Prosthetics, Bio3D Technologies, Laser GmbH, Prodways Group, 3T RPD Ltd., Photopolymerization, laser beam melting, Formlabs, Concept Laser, EOS GmbH Electro Optical Systems, Renishaw Plc, Groupe Gorge SA, Biomedical Modelling, Carbon Inc., Ottobock, Freedom innovation. The countries covered in the global 3D printed prosthetics market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The regions covered in the global 3D printed prosthetics market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The global 3D printed prosthetics market is segmented - 1) By Material: Polypropylene, Polyethylene, Acrylics, Polyurethane 2) By Type: Sockets, Limbs, Joints, Covers, Others 3) By End-User: Hospitals, Rehabilitation Centers, Prosthetic Clinics

The 3D medical imaging market consists of sales of 3D Ultrasound, X-Ray, CT scan, MRI, Hybrid Imaging equipment and related services. 3D medical imaging is used to create three dimensions’ visual representation of interior body parts for medical analysis with the help of computer-aided design (CAD) or a Magnetic Resonance Image (MRI). The global 3D medical imaging devices market is expected grow from $13.67 billion in 2020 to $14.52 billion in 2021 at a compound annual growth rate (CAGR) of 6.2%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $19.58 billion in 2025 at a CAGR of 8%. The 3D medical imaging market covered in this report is segmented by type into ultrasound, X-ray, CT scan, others. Increasing cases of injuries such as sports-related injuries contribute to the growth of the 3D medical imaging market. The increase in sports-related injuries is due to increasing participation of individuals in organized and unorganized sports activities. Moreover, the training of athletes with high strength and high load also results in more and more serious injuries. Sports injuries are mainly characterized by soft tissue injury. The use of 3D medical imaging devices such as ultrasound diagnosis, X-ray radiography, MRI imaging provides an accurate and objective basis for the diagnosis. The 3D medical imaging devices help in the examination of muscle fascia injury, tendon injury, ligament injury, meniscus injury, articular cartilage, and bone fracture. According to the Centre for the Disease Control and Prevention, it is estimated that there are 775,000 emergency room visits due to the injuries in children who are participating in the unorganized and organized sports activities. Thus, increase in demand for 3D medical imaging devices, favoring the market growth. The difficulties faced by the medical device industry owing to the COVID-19 outbreak such as the slowdown in orders and supply chain disruptions are likely to restraint the growth of the 3D medical imaging market over the next coming years. According to Medical Products Outsourcing (MPO) magazine published in April 2020, financial strains and supply chain disruptions are the major challenges faced by the medical devices industry. The manufactures are experiencing a modest slowdown in orders attributing to tight management of inventories due to fear of the spread of the virus and slow pace of reorders owing to the impact of the virus on businesses. Moreover, the managers are also hesitant in overseeing the new product launches in uncertain times. This scenario is predicted to act as a major factor restraining the growth of the market in the near future. 3D medical imaging device manufacturers are increasingly investing in Artificial Intelligence (AI) to improve the diagnosis by giving accurate, hard-number measurements. AI provides efficiency in medical imaging, particularly when it comes to detecting organs or anomalies. For instance, by combining image visualization and AI, cardiologists can measure ejection fraction with high precision and in a much shorter period of time. Ejection fraction is a measurement of the percentage of blood leaving the heart each time when it contracts. According to a report by Signify Research, in January 2019, capital investments in start-up companies developing 3D medical imaging AI solutions reached almost $580 million in 2018 from $270 million in 2017. In February 2020, Alphatec Holdings, Inc. (“ATEC” or the “Company”) acquired EOS imaging, SA for a purchase price of about $88 million. With this acquisition ATEC will integrat spine imaging and anatomical modelling for better operative performance and expected to significantly increase the demand for ATEC hardware and EOS systems. EOS Imaging is a France based medical device company leading in orthopedic medical imaging solutions. The major players covered in the global 3D medical imaging devices market are GE Healthcare, Royal Philips, Siemens AG, The Esaote Group, Intrasense SA, Materialise NV, Toshiba Group, Samsung Medison Co Ltd, Shimadzu Corporation, Analogic Corporation, Digirad Corporation, Del Medical Systems Group, Inc., Hologic Inc., Carestream Health Inc., Depuy Synthes Companies, Ambra Health, Fovia, Mach7 Technologies Ltd., Medtronic Inc, Barco NV, TomTec Imaging Systems GmbH, FUJIFILM, Carestream Health, Inc, Del Medical Systems, Digirad Corporation. The countries covered in the global 3D medical imaging devices market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The regions covered in the global 3D medical imaging devices market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The global 3D medical imaging devices market is segmented - 1) By Type: Ultrasound, X-ray, CT Scan, Others 2) By End User: Diagnostic Centers, Hospitals, Research Centers 3) By Application: Gynecology and Obstetrics, Cardiology, Neurology, Orthopedics, Oncology

The 3D printed medical implants market consist of sales of 3D printed medical implants and related services. In 3D printing technology, an artificial three dimensions physical object is created with the help of computer-aided design (CAD) or a magnetic resonance image (MRI), which can replaced the missing or defective body parts, to give support or recover damaged biological structure. 3D printed medical implants include 3D dental crowns, 3D dental bridges, 3D acetabular hip implants and shoulder implants. The 3D printed implants market covered in this report is segmented by application into dental, orthopedic, cranio-maxillofacial. The 3D printed medical implants market is also segmented by end users into medical and surgical centers, pharmaceutical companies, biotechnology industry, medical institution and by implantation technology into laser beam melting, electronic beam melting, droplet deposition, laminated deposition, two-photon polymerization. The global 3D printed implants market is expected to grow from $0.14 billion in 2020 to $0.15 billion in 2021 at a compound annual growth rate (CAGR) of 7.1%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The 3D printed medical implants market is expected to reach $0.27 billion in 2025 at a CAGR of 15.8%. Increasing prevalence of various medical conditions is driving the growth of the 3D printed medical implants market. As the number of people suffering from orthopedic, cardiac and dental diseases is increasing, the demand for 3D dental crowns, 3D dental bridges, 3D acetabular hip implants and shoulder implants and various other implants is rising. According to the World Health Organization (WHO), the US had around 65 million people suffering from periodontitis i.e. Inflammation and infection of the ligaments and bones that support the teeth. This mainly occurred due to rising prevalence of periodontitis, diabetes-related gangrene, osteoarthritis, and peripheral vascular disease. Similarly, the rise in prevalence of other medical conditions is driving the demand for use of 3D printed medical implants. Stringent approval process for selection of a new material to be used in 3D implants is a time-consuming process that acts as a restraint for the 3D Printed Medical Implants market. 3D Printing requires high-quality materials that should adhere to specific criteria set by regulatory bodies such as US FDA. These regulatory bodies provide procedure guidelines, requirements, and monitor material quality control. For example, the US FDA approved spinal implants made from titanium alloy, but it didn't approve titanium alloy to be used in any other medical device. For each new use of the material, manufacturing companies needs to get the approval again from regulatory bodies. This causes a lag in the manufacturer's operational cycle and delays the product launch, thus affecting sales and restraining the growth of the 3D printed medical implants market. Many companies in this market are collaborating with various hospitals and rehabilitation centers to provide customizable devices for specific needs of patients. These collaboration are aimed to be mutually beneficial for both, as the companies can use the network of the hospitals to promote their product and the hospitals would get customizable devices at their convenience. For example, In January 2019, Renishaw, a global manufacturer of 3D implants, collaborated with University Dental Hospital of Wales (UDH), Cardiff, to help overcome challenges associated with surgical implants. This would help Renishaw to work with hospitals and become the major supplier of medical additive manufacturing devices. Similarly, in January 2019, Hospital for Special Surgery (HSS) collaborated with Lima Corporate to provide a 3D printed facility for orthopedic implants. This collaboration would help HSS to use Lima's technology to produce new innovative products for orthopedic joint care and to expand its product portfolio. The US FDA's Center for Devices and Radiological Health (CDRH) is the regulatory authority for companies who manufacture, repackage, relabel, and/or import medical devices sold in the United States. The medical devices made using 3D printing technology are subject to regulatory requirements before they are marketed (premarket requirements), and also after they are marketed (post market requirements). FDA classifies 3D printed medical devices into three classes, i.e., Class I, II, and III, with regulatory controls minimum for class I devices and maximum for class III devices. Most class III devices require premarket approval whereas class I devices are exempted from the approval. The manufacturers of 3D printed medical implants are required to establish and follow quality systems to ensure that their products consistently meet applicable requirements and specifications. The manufacturers also need to comply with FDA's standards regarding device design, manufacturing, and testing considerations during the development of 3D printed medical devices. In August 2018, Stryker acquired K2M for $1.4 billion.K2M, established in 2004 and headquartered at Leesburg, US, provides complex spinal implants and minimally invasive solutions focused on achieving three-dimensional body balance. Stryker aims to expand its product portfolio through this acquisition and achieve leadership in the spine and neurotechnology market. Major players in the 3D printed medical implants market are 3D Systems Corporations, Stratasys Ltd, Arcam AB, EnvisionTEC and SLM Solutions Group AG. The regions covered in the 3D printed medical implants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the 3D printed medical implants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The global 3D printed implants market is segmented - 1) By Application: Dental, Orthopedic, Cranio-maxillofacial 2) By End Users: Medical And Surgical Centers, Pharmaceutical Companies, Biotechnology Industry, Medical Institution 3) By Implantation Technology: Laser Beam Melting, Electronic Beam Melting, Droplet Deposition, Laminated Deposition, Two-photon Polymerization

The 3D cell culture technologies market consist of sales of 3D cell culture technologies and related services. Some of the 3D cell culture technologies include microfluidics, hydrogels scaffolds, scaffold-free 3D cell culture techniques, spheroids, cube, spherical droplet, stacked plate, magnetic bead, organ-on-chips and other technologies. The 3D cell culture technologies market does not include sales of cell culture consumables and instruments. This market is segmented into scaffold based, scaffold-free technologies and 3D bioreactors. The 3D cell culture technologies market covered in this report is segmented by type into scaffold-based, scaffold-free, 3D bioreactors. The 3D cell culture technologies market is also segmented by end users into research laboratories and institutes, biotechnology and pharmaceutical companies, hospitals and diagnostic centers, other end users; by scaffold-based into hydrogels, polymeric scaffolds, micropatterned surface microplates; by scaffold-free into hanging drop microplates, spheroid microplates, microfluidic 3D cell culture, magnetic levitations & 3d bioprinting and by application into cancer research, stem cell research, drug discovery, regenerative medicine. The global 3D cell culture technologies market is expected to grow from $1.63 billion in 2020 to $1.88 billion in 2021 at a compound annual growth rate (CAGR) of 15.3%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The 3D cell culture technologies market is expected to reach $4.23 billion in 2025 at a CAGR of 22.5%. The increasing requirement for organ transplantation is driving the 3D cell culture technologies market. 3D cell culture helps in forming a three-dimensional structure which further helps in mimicking the tissue or organ and therefore helps in organ transplantation. 3D cell structures are capable of tissue and organ regeneration as well as providing the provision for drug toxicology screening. According to the U.S. government information on organ donation and transplantation, 39,718 transplants were performed in 2019 and above 109,000 people are waiting for the transplant as of September 2020. The possibility of contaminating the cells is restricting the 3D cell culture technologies market. Contamination of the cell culture refers to the presence of bacteria, moulds, yeasts, viruses, and mycoplasma that can adversely affect the cell culture. Contamination usually occurs when the cells are mishandled or due to the lack of adequate care, as a result the process of regeneration may get affected. According to a study conducted by Yale and Tuff's university, it was found that 3D cultures are more complex than 2D cell cultures and they require a more controlled cellular environment in order to mimic structures for tissue or organ transplants. Therefore, probability of cell culture contamination is relatively higher in 3D cell cultures. Implementing the latest technology is the latest trend in the 3D cell culture market. For example, various companies have adopted one such advancement into the market for 3D cell culture, this is the use of the vivo/vitro environment. Cell expansion and interactions under 2D are not appropriate in vitro models but when compared with 3D cell culture technique, it offers a better cell culture environment. The vitro environment enables researchers or doctors to conduct the procedure in a controlled environment outside the organism. This procedure is gaining importance as it plays a vital role in monitoring the health of patients. FDA approved Biotek's 3D cell expansion system to be used as a medical device. It also approved Biotek's Polycaprolactone (PCL) which is a biodegradable polyester material that is used in many FDA approved implants and drug delivery devices. FDA regulates the cell culture technologies under title 21, sec 864.2240. FDA states that cell and tissue culture technologies should be labelled or mentioned as sterile, or else they would be removed from the good manufacturing practice of the quality system. Each technology unit should maintain procedures to receive, review, and evaluate complaints. These procedures should also include the consistent documentation of the receipts. In 2018, Greiner Bio-One North America Inc. acquired 3D cell culture technology platform of Nano 3D Biosciences Inc. for an undisclosed amount. This will not only help Greiner Bio-One expand its portfolio but it will also help it strengthen its reach in the market. 3D cell culture is a disruptive technology in this market, it will help by improving the quality of results and pave new pathways towards disease treatment and prevention. Nano 3D Biosciences was established in 2008 and is headquartered in Texas, USA. Major players in the 3D cell culture technologies market are Nano3D Biosciences Corning Inc., Merck & Co., 3D Biotek LLC, 3D Biomatrix and Thermo Fisher Scientific. The regions covered in the 3D cell culture technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the 3D cell culture technologies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The global 3D cell culture technologies market is segmented - 1) By Type: Scaffold-based, Scaffold-free, 3D Bioreactors 2) By End Users: Research Laboratories and Institutes, Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostic Centers, Other End Users 3) By Scaffold-Based: Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates 4) By Scaffold-Free: Hanging Drop Microplates, Spheroid Microplates, Microfluidic 3D Cell Culture, Magnetic Levitations & 3D Bioprinting 5) By Application: Cancer Research, Stem Cell Research, Drug Discovery, Regenerative Medicine

The 3D diagnostic imaging services market consists of revenues generated by the use of 3D diagnostic imaging procedures such as 3D X-rays, 3D ultrasound, MRI, and other 3D nuclear imaging techniques (PET, SPECT) to diagnose patients with chronic diseases. The 3D diagnostic imaging technique provides advanced services that help in various applications such as oncology, cardiology, orthopedics and others. 3D diagnostic imaging is used to create three dimensional visual representations of interior body parts for medical analysis with the help of computer-aided design (CAD) or a Magnetic Resonance Image (MRI) technology. The 3D diagnostic imaging services market covered in the report is segmented by technique into ultrasound, MRI, X-ray, computed tomography, others and by application into oncology, cardiology, orthopedics, others. The global 3D diagnostic imaging services market is expected grow from $172.25 billion in 2020 to $192.91 billion in 2021 at a compound annual growth rate (CAGR) of 12%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The 3D diagnostic imaging services market is expected to reach $255.4 billion in 2025 at a CAGR of 7%. The demand for point-of-care testing (PoCT) has been steadily increasing over the years. The growth in demand is likely to continue and drive the market for 3D diagnostic imaging services market. This is because PoCT allows physicians and medical staff to accurately achieve real-time, lab-quality diagnostic results within minutes rather than hours. Also, the changing healthcare delivery system is aimed at delivering cost effective care at patient’s home. In most of the countries, especially developing countries, more effective care for infectious diseases is needed. PoCT technologies provide effective care with easy-to-use devices and improved analytical performance and recent improvements in the speed, usability and affordability of medical imaging with 3D integration have greatly expanded the capabilities of PoCT testing systems. These advances are greatly driving the 3D diagnostic imaging services market. The 3D diagnostic imaging services market is constrained by the shortage of qualified and skilled healthcare resources. The main reasons are aging workforce, complexity of the latest procedures and their reluctance towards learning the new procedures, and shrinking number of accredited training programs. A report from the International Labor Organization estimates a global deficit of over 10.3 million skilled health professionals, and more than half of the deficit, totaling 7.1 million (69%), is in Asia. The shortage of skilled workforce is expected to affect the 3D diagnostic imaging services market. Therefore, there is an urgent need to train more healthcare professionals in the latest procedures and technologies including 3D imaging to enable accurate diagnosis and treatment in the most efficient manner. Introduction of improved data storage and information sharing systems such as medical cloud technology is creating more growth opportunities for 3D diagnostic imaging. This is because medical imaging requires adequate resources to process, store, exchange and use large quantities of medical data for appropriate diagnostic and treatment decisions, and advanced cloud computing in medical imaging addresses these concerns. Cloud computing is an emerging solution for questions related to delivering complex services and data interchange over the internet. Cloud computing technology enables medical data sharing across regions, allowing more patients to obtain the medical resources they need. It allows easy retrieval of data and provides doctors with more convenient clinical image data services (clear and informative images). Medical cloud imaging has become an important field of cloud computing. In January 2020, Metropolis Healthcare, a chain of diagnostic companies, acquired 51% stake in Shraddha Diagnostic Centre for Rs 9.36 Crores ($1.27 million). This acquisition helps Metropolis Healthcare expand its geographical reach in 9 cities and towns in India. Shraddha Diagnostics is a private company that majorly serves the B2B segment. Major players in the 3D diagnostic imaging services market are Laboratory Corporation of America Holdings, Quest Diagnostics Inc, Alere Inc., Bio-Reference Laboratories, DaVita Healthcare Partners Inc, Genomic Health Inc., Myriad Genetics Inc., NeoGenomics Inc., Sonic Healthcare Limited, and Spectra Laboratories. The regions covered in the 3D diagnostic imaging services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the 3D diagnostic imaging services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The global 3D diagnostic imaging services market is segmented - 1) By Technique: Ultrasound, MRI, X-ray, Computed Tomography, Others 2) By Application: Oncology, Cardiology, Orthopedic, Others 3) By End User: Diagnostic Centers, Hospitals, Research Centers

The 3D printing service market consists of services provided by 3D printing service providers to companies in any of the forms of 3D printed parts, rapid prototyping, components produced by 3D printers, and related services such as software upgrades and maintenance. The global 3D printing services market is expected grow from $4.97 billion in 2020 to $6.76 billion in 2021 at a compound annual growth rate (CAGR) of 36%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $16.3 billion in 2025 at a CAGR of 25%. The 3D printing service market covered in this report is segmented by service offering into tooling; parts production; software services; system maintenance; expert service and by end user into consumer products; automotive; healthcare; aerospace & defense. Reduction in manufacturing cost and process downtime contributed to the growth of the 3D printing services market. 3D printing technology helps companies greatly reduce their manufacturing costs, reduce downtime and minimize waste. With the use of 3D printing for prototyping, companies can significantly lower the cost of developing new products. The minimal labor/workforce involved in this process also contributes to the low manufacturing costs. Due to 3D printing the manufacturing time can be reduced from months to days. For instance, to print a phone case it takes around 20 minutes, and similarly a 2*4 Lego can be printed in 4 minutes. Therefore, reduction in manufacturing costs and process downtime increased demand for the 3D printing services market. Intellectual property on printing anything which has property rights issues is considered unauthorized and subjected to an act of patent infringement. This factor hampers the growth of 3D printing service market growth. In 3D printing market, the products which are available to print are less. 3D printing products are widely used in the health care industry. Pharmaceutical companies can drastically improve the drug research and development (R&D) by 3D printing as the technology could even be used to print human organs and tissue. However, to print an organ one should buy the patent of the 3D building product code, which makes the product cost high. Therefore, intellectual property on printing products hampers the growth of the 3D printing service market. 3D printing services providers are implementing cloud-based 3D printing services. Cloud-based 3D printing management platform can be used by any individual, enterprises, schools, and service bureaus to render, fix, store 3D design securely and stream 3D design to the 3D printer with complete data tracking and analytics. Ultimaker, one of the global leaders in desktop 3D printing, launched Ultimaker Cloud platform in TCT Asia 2019 event in China. It will form a crucial platform solution with capabilities to simplify the user workflow ensuring compatibility with a wide variety of software applications and materials. In December 2020, Stratasys Ltd., an American-Israeli manufacturer of 3D printers and 3D production systems, signed an agreement to acquire 3D printing start-up Origin Inc. for total consideration of up to $100 million, including cash and stock. The acquisition will enable Stratasys to use Origin's photopolymer platform and extensive materials ecosystem to expand into the mass production parts segment with a next-generation photopolymer platform. The major players covered in the global 3D printing services market are 3D Systems Corporation, Stratasys, Materialise NV, ExOne, Arcam, ProtoLabs – 3D Rapid Prototyping Company, HP Inc., SLM Solutions Group, ARC Group Worldwide, Carbon, Concept Laser (GE), Cookson Precious Metals, EnvisionTEC, GE Additive, Groupe Gorgé, Höganäs, Markforged, Mcor Technologies, Optomec, ReaLizer, Renishaw, Organovo, Nano Dimensions. The countries covered in the global 3D printing services market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The regions covered in the global 3D printing services market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The global 3D printing services market is segmented - 1) By Service Offering: Tooling, Parts Production, Software Services, System Maintance, Expert Service 2) By End User: Consumer Products, Automotive, Healthcare, Aerospace And Defense 3) By Application: Prototyping, Tooling, Functional Parts Manufacturing

Diagnostic And Monitoring Ophthalmic Devices And Equipment Market Definition

The diagnostic and monitoring ophthalmic devices and equipment market consists of sales of diagnostic and monitoring ophthalmic devices and equipment and related services by entities (organizations, sole traders and partnerships) that manufacture diagnostic and monitoring ophthalmic devices and equipment. The diagnostic and monitoring ophthalmic devices are used for the diagnosis and monitoring of diseases related to the retina and cornea by measuring affix lenses and refractive errors. These devices also help to identify the power of the intra ocular lens (IOLs) and analyze the visual field. These devices include ultrasound imaging systems, optical coherence tomography scanners, ophthalmoscopes, corneal topographers, specular microscopes, slit lamps, fundus cameras, anomaloscope, haploscope, ophthalmic lens gauge, stereopsis measuring Instrument, retinoscopes, stereoscope and others.

Medical Devices Market Definition

The medical devices market consists of sales of medical equipment or devices and related services by entities (organizations, sole traders and partnerships) that manufacture medical equipment or devices which are used in the diagnosis, treatment and monitoring of medical conditions. The medical device industry includes establishments that manufacture medical equipment or devices such as in-vitro diagnostic devices, diagnostic imaging equipment, dental equipment and supplies, ophthalmic devices, cardiovascular devices, hospital supplies and other medical devices.